CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+1.91%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$14.7B
(+0.67%)
Cap. Flow
+$182M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
956
New
63
Increased
335
Reduced
301
Closed
69
Top Buys
| 1 |
NVIDIA
NVDA
|
$92M |
| 2 |
Johnson & Johnson
JNJ
|
$54.5M |
| 3 |
AstraZeneca
AZN
|
$46.3M |
| 4 |
Autodesk
ADSK
|
$40.5M |
| 5 |
Mercado Libre
MELI
|
$39.4M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$92.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$85.8M |
| 3 |
GE Aerospace
GE
|
$62.1M |
| 4 |
Alibaba
BABA
|
$60.1M |
| 5 |
Merck
MRK
|
$49.2M |
Sector Composition
| 1 | Healthcare | 32.1% |
| 2 | Technology | 24.54% |
| 3 | Financials | 9.08% |
| 4 | Communication Services | 8.24% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
MannKind Corp
MNKD
$1.79B
| – | – |
-11,500
| Closed | -$63K |
|
902
NetEase
NTES
$86B
| – | – |
-38,150
| Closed | -$4.4M |
|
903
NovoCure
NVCR
$1.36B
| $0 | ﹤0.01% |
3
| – | – |
|
904
News Corp Class A
NWSA
$16B
| – | – |
-23,724
| Closed | -$611K |
|
905
Organon & Co
OGN
$2.44B
| – | – |
-51,274
| Closed | -$1.55M |
|
906
Pan American Silver
PAAS
$12.4B
| – | – |
-89,600
| Closed | -$2.56M |
|
907
Invesco WilderHill Clean Energy ETF
PBW
$349M
| – | – |
-4,620
| Closed | -$431K |
|
908
PotlatchDeltic
PCH
$3.16B
| – | – |
-32,428
| Closed | -$1.72M |
|
909
Pentair
PNR
$17.5B
| – | – |
-17
| Closed | -$1K |
|
910
Riot Platforms
RIOT
$5.2B
| – | – |
-5,840
| Closed | -$220K |
|
911
Rollins
ROL
$27.3B
| – | – |
-39,835
| Closed | -$1.36M |
|
912
SAP
SAP
$314B
| – | – |
-10
| Closed | -$1K |
|
913
ARS Pharmaceuticals
SPRY
$1.11B
| – | – |
-196,557
| Closed | -$6.07M |
|
914
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
915
Sutro Biopharma
STRO
$84.8M
| – | – |
-366,207
| Closed | -$6.81M |
|
916
Theravance Biopharma
TBPH
$704M
| – | – |
-475,696
| Closed | -$6.91M |
|
917
Trip.com Group
TCOM
$46.5B
| – | – |
-62,910
| Closed | -$2.23M |
|
918
Taylor Morrison
TMHC
$6.66B
| – | – |
-124,810
| Closed | -$3.3M |
|
919
Trade Desk
TTD
$26.5B
| – | – |
-2,860
| Closed | -$221K |
|
920
UDR
UDR
$12.6B
| – | – |
-6,499
| Closed | -$318K |
|